L
LinguaFlex
Developing the minimally-invasive sleep apnea solution, designed to keep sleeping soundly all night long
About LinguaFlex
LinguaFlex is a medical device company specializing in innovative solutions for obstructive sleep apnea, a condition where the airway is blocked during sleep, leading to serious health issues like hypertension and heart attacks. The company's core product is a soft, flexible device placed under the tongue to prevent it from relaxing backward, thus keeping the airway open. This minimally invasive device is inserted in a quick, 10-minute procedure under light sedation, allowing patients to go home the same day. LinguaFlex serves patients suffering from sleep apnea, operating in the medical device market. The business model revolves around developing and distributing this patented technology, generating revenue through device sales and potential future licensing agreements. Founded by Dr. Ira Sanders, a renowned Otolaryngologist, LinguaFlex collaborates with leading researchers in otolaryngology and sleep medicine to advance its life-changing technology.
Source: Dealroom company dataAt a glance
- Founded
- 2007
- Headquarters
- Pittsburgh, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about LinguaFlex on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See LinguaFlex on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.